Hotline – Election Day Closure

ATTENTION: HealthWell Foundation’s hotline will be closed on Tuesday, November 3, 2020 to allow our contact center team the flexibility to safely vote. The hotline will re-open on Wednesday, November 4, 2020 at 9:00 a.m. We encourage you to continue to use our Patient, Pharmacy and Provider Portals during this time.  Please note: if you are contacting us about a payment or grant, it is faster to email us at grants@healthwellfoundation.org.  The HealthWell Team.

 

 

Dismiss alert
By Real World Health Care Editorial Staff  |  Dec 2, 2015

Personalized Medicine & Companion Diagnostics: Speaking with Dr. Razelle Kurzrock

Real World Health Care recently sat down with Dr. Razelle Kurzrock, Director, Center for Personalized Cancer Therapy & Clinical Trials Office, University of California San Diego Moores Cancer Center, to discuss the present state and future direction of genomics and immunotherapy. Real World Health Care:  Why was the Center for…more.

By Real World Health Care Editorial Staff  |  Nov 18, 2015

Personalized Medicine & Companion Diagnostics: Speaking with Keith Stewart, Director of the Mayo Clinic Center for Individualized Medicine

Editor’s Note: This week, we sit down with Keith Stewart, director of the Mayo Clinic Center for Individualized Medicine. Real World Health Care:  Why was the Center for Individualized Medicine formed at the Mayo Clinic? What were its initial goals and how have those goals changed? Keith Stewart:   The Center…more.

By Emily Burke, Ph.D., Director of Instruction, BiotechPrimer.com  |  Nov 4, 2015

Targeting Breast Cancer: The Subtypes of Breast Cancer

Editor’s Note: Based on an article originally published in Biotech Primer Weekly. Hearing your doctor utter the words HER2-positive, HR-positive, triple-negative or BRCA mutation can be devastating — even for the most resilient person. Simply put, all are linked to breast cancer. Breast cancer is complex, and a diagnosis can…more.

By Real World Health Care Editorial Staff  |  Oct 28, 2015

Personalized Medicine & Companion Diagnostics: Speaking with Dr. Joshua Cohen, Tufts Center for the Study of Drug Development

Editor’s Note: In August, the Tufts Center for the Study of Drug Development (CSDD) hosted a roundtable of R&D leaders focused on development of companion diagnostics that can show their use in conjunction with personalized therapeutics that will lead to positive health outcomes. We spoke with Joshua P. Cohen, Ph.D.,…more.

By Emily Burke, Ph.D., Director of Instruction, BiotechPrimer.com  |  Oct 14, 2015

Personalized Medicine & Companion Diagnostics: What You Need to Know

Personalized medicine – also referred to as precision or stratified medicine – is already changing the way we diagnose and treat disease. As our ability to obtain and analyze large amounts of genetic data increases, so too will the range and power of these personalized tools. The idea of personalized…more.

Close menu